SYKEHUSET SORLANDET HF has a total of 25 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2012. It filed its patents most often in Japan, Republic of Korea and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are IMMURX INC, METRIS THERAPEUTICS LIMITED and PEGBIO CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 4 | |
#2 | Republic of Korea | 4 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | EAPO (Eurasian Patent Organization) | 1 | |
#9 | Hungary | 1 | |
#10 | Mexico | 1 | |
#11 | Serbia | 1 | |
#12 | Slovenia | 1 | |
#13 | WIPO (World Intellectual Property Organization) | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Kersten Christian | 18 |
#2 | Cameron Marte Gronlie | 17 |
#3 | Mjaland Svein | 16 |
#4 | Christian Kersten | 5 |
#5 | Svein Mjaeland | 4 |
#6 | Marte Garoenlie Cameron | 4 |
#7 | Cameron Marte Grønlie | 1 |
#8 | Svein Mjaland | 1 |
#9 | Mj Not Aland Svein | 1 |
#10 | Mjåland Svein | 1 |
Publication | Filing date | Title |
---|---|---|
AU2013362134A1 | EGFR targeted therapy of neurological disorders and pain | |
EP2729173A1 | Egfr targeted therapy |